GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source Last Updated
PSICQUIC March 30, 2022
Displaying entries 2701 - 2725 of 4050 in total
Antibody Patient Onset (days) Symptom GlyTouCan ID ▼ Arbitrary Fluorescence Units (AFU)
IgA Patient 1 10 moderate
G26125KY
435
IgA Patient 1 22 moderate
G26125KY
432
IgA Patient 1 6 moderate
G26125KY
444
IgG Patient 1 10 moderate
G26125KY
113
IgG Patient 1 22 moderate
G26125KY
114
IgG Patient 1 6 moderate
G26125KY
114
IgM Patient 1 10 moderate
G26125KY
32
IgM Patient 1 22 moderate
G26125KY
34
IgM Patient 1 6 moderate
G26125KY
34
IgA Patient 2 15 mild
G26125KY
461
IgA Patient 2 24 mild
G26125KY
521
IgG Patient 2 15 mild
G26125KY
14323
IgG Patient 2 24 mild
G26125KY
13804
IgM Patient 2 15 mild
G26125KY
236
IgM Patient 2 24 mild
G26125KY
259
IgA Patient 2 3 mild
G26125KY
634
IgG Patient 2 3 mild
G26125KY
26641
IgM Patient 2 3 mild
G26125KY
394
IgA Patient 3 -180 mild
G26125KY
2520
IgA Patient 3 11 mild
G26125KY
2531
IgG Patient 3 -180 mild
G26125KY
1382
IgM Patient 3 -180 mild
G26125KY
7474
IgA Patient 3 4 mild
G26125KY
2601
IgG Patient 3 11 mild
G26125KY
1785
IgG Patient 3 4 mild
G26125KY
1842

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.0

Last updated: December 9, 2024